INHIBITEX Stock Price
$26 
Change:
0.01 0.01% Volume:
131,649
Live Stock Prices
You need Flash Player to see the chart, please download from the link below
Todays Chart
You need Flash Player to see the chart, please download from the link below
Month Chart
Todays High: 26.005 | Todays Low: 25.99 | Open: 25.995 | Last Close: 25.96
52 Wk High: 26.005 | 52 Wk Low: 25.99 | Todays Pivot: 26.00 | Pre market open: 25.96
Sector: 
Online News For Inhibitex
|
A buyout could send this agricultural stock up 25% - MSN Money
Tue, 14 May 2013 22:28based energy construction company Shaw Group, which was bought for $46 a share, a 72% premium to its $27 share price. It also included Bristol-Myers Squibb (BMY) paying $26 a share to buy biotech company Inhibitex, a huge 163% premium that ranked ...
|
|
Bristol-Myers Squibb touts effectiveness of experimental hepatitis C medication - The Star-Ledger - NJ.com
Tue, 23 Apr 2013 17:58The company last year took a $1.8 billion charge and stopped development of an experimental hepatitis C drug gained in its February 2012 purchase of Inhibitex Inc. after patients on the pill developed heart failure. The three drugs in Bristol-Myers's ...
|
|
Synergy On Sale: Why This Opportunity Shouldn't Be Missed - Seeking Alpha
Thu, 25 Apr 2013 15:51As many on Wall Street know, Board Chairman Gabriel Cerrone has a track record of ushering in high take-out premiums for development-stage biotech companies (he championed the $2.5 billion sale of Inhibitex to Bristol-Myers Squibb (BMY) in early 2012).
|
|
Gabriele Cerrone il ciociaro di New York che vuole rilanciare il biotech italiano - La Repubblica
Mon, 13 May 2013 06:28Cerrone sei anni fa ha fuso FermaVir con Inhibitex, un'altra società del suo parco, che operava in un settore analogo, la sperimentazione su un farmaco contro l'epatite C. Bene, l'intera Inhibitex è stata rilevata nel gennaio 2012 da Bristol-Myers per ...
|
|
Einsatz verdreifacht So viel Kurspower steckt in Biotech - Aktien - Finanzen100
Wed, 08 May 2013 15:46Beispiele aus dem vergangenen Jahr seien die Übernahmen von Inhibitex, Micromet, Amylin und Human Genome Science. „Die Übernahmewelle könnte noch eine Weile anhalten“, meint Flury, die über 15 Jahre Investmenterfahrung verfügt. Biotechnologie ...
|
INHX Chart
You need Flash Player to see the chart, please download from the link below
Want To Add This Quote To Your Site?
With our stock widgets you can add a real time Inhibitex quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for INHX to choose from. Visit here to build your stock quote widget »
